Prof. Dr. İLHAMİ BERBER | AVESİS

Akademik Veri Yönetim Sistemi

Yayınlar & Eserler

Makaleler 116

1. Ameliorative effects of humic acid on copper-induced liver injury via antioxidant and chelating mechanisms

ÇAĞIN Y. F., ATAYAN Y., ÖZHAN O., BERBER İ., YILDIZ A., DOĞRU F., et al.

Medicine Science , cilt.14, sa.4, ss.1272-1279, 2025 (TRDizin)

2. The role of heparin in autologous stem cell mobilization in patients with multiple myeloma

SARICI A., ERKURT M. A., Yilmaz S., Demircioglu S., BERBER İ., Basturk A., et al.

Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded)

3. The comparison of cyclophosphamide at different dose levels for stem cell mobilization in multiple myeloma

Karakus A., Hatipoglu U., Katircilar Y., ERKURT M. A., Yilmaz S., Cagliyan G. A., et al.

Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded)

4. Fresh and cryopreserved stem cell transplantation in myeloma patients: Does it make a difference on transplant outcomes?

ERKURT M. A., Yilmaz S., NAMDAROĞLU S., Demircioglu S., SARICI A., Cirik S., et al.

Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded)

5. The impact of second allogeneic hematopoietic stem cell transplantation as salvage therapy for hematologic diseases after a first allogeneic transplantation

BATGİ H., Zorlu T., ERKURT M. A., UZAY A., Hindilerden I. Y., Pepeler M. S., et al.

Transfusion and Apheresis Science , cilt.64, sa.4, 2025 (SCI-Expanded)

6. Disruption of kinesthesia and position sense in the ankle joint is an independent predictor of falls in elderly patients undergoing hemodialysis

Ulutas N. S., Bentli R., BERBER I., Ulutaş Ö.

Annals of Medical Research , cilt.32, sa.3, ss.126-130, 2025 (Hakemli Dergi)

7. What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?

Ulas T., NAMDAROĞLU S., Hindilerden I. Y., ERKURT M. A., Erer K., Yigenoglu T. N., et al.

Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded)

8. Effectiveness of ibrutinib in the management of chronic GVHD

ERKURT M. A., SARICI A., Sahin A., BERBER İ., Korkmaz G., KUKU İ., et al.

Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded)

9. Efficacy of Ruxolitinib in the management of chronic GVHD

Giden A. O., ERKURT M. A., Hindilerden I. Y., Hidayet E., BERBER İ., Tiryaki T. O., et al.

Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded)

10. The role of ruxolitinib in the management of acute GVHD

NAMDAROĞLU S., Hidayet E., Aydin M. S., ERKURT M. A., BERBER İ., Cinar O. E., et al.

Transfusion and Apheresis Science , cilt.64, sa.1, 2025 (SCI-Expanded)

11. Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin’s Lymphoma: A Multi-Center Retrospective Study on Survival and Safety

Bakirtas M., Hindilerden I. Y., Ulu B. U., Ekinci O., Dogu M. H., Aydogdu I., et al.

Indian Journal of Hematology and Blood Transfusion , 2025 (SCI-Expanded)

12. Relationship between reticular fibrosis with platelet surface markers (CD41A, CD42A, CD42B, CD61) and prognostic markers (WBC, PLT) in acute promyelocytic leukemia

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.

ACTA HAEMATOLOGICA POLONICA , cilt.55, 2024 (Scopus)

13. Effects of extracorporeal photopheresis on survival in chronic graft versus host disease

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., BİÇİM S., et al.

MARMARA MEDICAL JOURNAL , cilt.37, 2024 (ESCI)

14. The role of therapeutic plasma exchange in the treatment of patients with septic shock- single center experience

Çelik S., ERKURT M. A., SARICI A., KUKU İ., KAYA E., BERBER İ., et al.

Journal of Current Hematology &amp; Oncology Research , cilt.2, 2024 (Hakemli Dergi)

15. Prophylactic intravenous immunoglobulin use in allogeneic stem cell transplantation; does intravenous immunoglobulin affect survival, sepsis, and engraftment time?

KAYA A., BERBER İ., KAYA E., ERKURT M. A., BİÇİM S., ARSLAN S., et al.

IRAQI JOURNAL OF HEMATOLOGY , cilt.13, 2024 (ESCI)

16. Retrospective evaluation of indications for therapeutic plasmapheresis procedures applied in our center

ERYILDIZ S., KUKU İ., KAYA E., ERKURT M. A., BERBER İ.

Journal of Current Hematology &amp; Oncology Research , cilt.2, 2024 (Hakemli Dergi)

17. Evaluation of busulfan, cyclophosphamide, and etoposide as a preparation regimen for autologous stem cell transplantation in Hodgkin’s lymphoma patients

BİÇİM S., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., KAYA A., et al.

IRAQI JOURNAL OF HEMATOLOGY , cilt.13, 2024 (ESCI)

Creative Commons License

18. How are the Results of Allogeneic Stem Cell Transplantation in Elderly Patients? A Single-center Experience

Uysal A., ERKURT M. A., KUKU I., Kaya E., BERBER I., SARICI A., et al.

ACTA ONCOLOGICA TURCICA , cilt.56, sa.2, ss.106-113, 2023 (Hakemli Dergi)

Creative Commons License

19. The Experience of Ibrutinib in Chronic Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

Sarıcı A., Erkurt M. A., Kuku İ., Kaya E., Berber İ., Biçim S., et al.

İstanbul Medical Journal , cilt.24, sa.2, ss.216-220, 2023 (Hakemli Dergi)

20. A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera

SERİN İ., DOĞU M., EKINCI O., ÇAĞLIYAN G. A., BAŞTÜRK A., ARAS M. R., et al.

İstanbul Medical Journal , cilt.24, sa.2, ss.120-125, 2023 (Hakemli Dergi)

21. The effect of CD 34+ stem cell dose on both short-term and long-term outcomes of autologous stem cell transplantation in multiple myeloma

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.

Annals of Medical Research , cilt.30, sa.3, ss.331-336, 2023 (Hakemli Dergi)

22. Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Thalassemia: A Single-Center Experience and Literature Review

UYSAL A., ERKURT M. A., SARICI A., KUKU İ., BİÇİM S., HİDAYET E., et al.

Fırat Tıp Dergisi , cilt.28, sa.1, ss.46-50, 2023 (Hakemli Dergi)

23. A case of malignant melanoma presented with lombar vertebra fracture

SARICI A., KUKU İ., BERBER İ., ERKURT M. A., ER ULUBABA H., BİÇİM S., et al.

Journal of Current Hematology & Oncology Research , cilt.1, 2023 (Hakemli Dergi)

Creative Commons License

24. Effect of tyrosine kinase inhibitor and conventional chemotherapy on COVID 19 antibody level in hematological patients

KAYA A., BERBER İ., KUKU İ., ÇELİK S., KAYA E., BİÇİM S., et al.

Journal of Current Hematology & Oncology Research , cilt.1, 2023 (Hakemli Dergi)

Creative Commons License

25. The effect of preemptive use of plerixafor on stem cell mobilization in patients with lymphoma and multiple myeloma

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.

MARMARA MEDICAL JOURNAL , cilt.36, 2023 (ESCI)

Creative Commons License

26. The frequency of HLA A, B, C, DP, DQ, DR allele in patients of Turkish and Syrian nationals with allogeneic stem cell transplantation

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., BİÇİM S., et al.

IRAQI JOURNAL OF HEMATOLOGY , cilt.11, sa.2, ss.110-117, 2022 (Hakemli Dergi)

27. The effect of G-CSF used after allogeneic hematopoietic stem cell transplantation on engraftment times and platelet suspension replacement numbers.

Sarıcı A., Erkurt M. A., Kuku İ., Kaya E., Berber İ., Biçim S., et al.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis , cilt.61, sa.6, ss.103482, 2022 (SCI-Expanded)

28. Identification of lymphocyte subgroups with flow cytometry in COVID-19 patients

BERBER İ., KIRICI BERBER N., SARICI A., GÖZÜKARA BAĞ H. G., BİÇİM S., TURGUT B., et al.

JOURNAL OF HEALTH SCIENCES AND MEDICINE , cilt.5, sa.4, ss.1183-1189, 2022 (Hakemli Dergi)

29. Effects Of Ethnicity On Allogenic Stem Cell Mobilization

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.

International Journal of Clinical Images and Medical Reviews , cilt.2, sa.2, ss.1-4, 2022 (Hakemli Dergi)

30. Convalescent plasma therapy in COVID-19

UYSAL A., ERKURT M. A., KUKU İ., SARICI A., BİÇİM S., KAYA E., et al.

Medicine Science , cilt.11, sa.2, ss.920-923, 2022 (Hakemli Dergi)

31. The effect of comorbidity on survival and collected CD34+cell counts in autologous hematopoietic stem cell transplant patients

SARICI A., ERKURT M. A., KUKU İ., Bahcecioglu O. F., Bicim S., KAYA E., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.61, sa.1, 2022 (SCI-Expanded)

32. Etiological evaluation and the role of plasma exchange treatment in trombotic microangiopathies: A retrospective analysis from Eastern Anatolia

HİDAYET E., ERKURT M. A., SARICI A., KUKU İ., BERBER İ., KAYA E., et al.

Medicine Science , cilt.11, 2022 (Hakemli Dergi)

33. The effect of cryopreserved and noncryopreserved stem cells on the outcome of autologous stem-cell transplantation in multiple myeloma patients: A single-center experience

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.

EGYPTIAN JOURNAL OF HAEMATOLOGY , cilt.47, 2022 (Hakemli Dergi)

34. Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers

Basci S., Ata N., Altuntas F., Yigenoglu T. N., Dal M. S., Korkmaz S., et al.

INTERNAL AND EMERGENCY MEDICINE , cilt.17, sa.1, ss.135-139, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

35. Non-infectious Complications in Patients with Allogeneic Hematopoietic Stem Cell Transplantation- Single Center Experience from Eastern Anatolia

KARAMAN S., SARICI A., ERKURT M. A., BİÇİM S., HİDAYET E., KAYA A., et al.

ACTA ONCOLOGICA TURCICA , cilt.55, 2022 (Hakemli Dergi)

36. Predictive Significance of Mean Platelet Volume and Platelet Distribution Width Level in Immune Thrombocytopenia Patients Treated With Steroids

KAYA A., KUKU İ., ERKURT M. A., KAYA E., BERBER İ., SARICI A., et al.

International Journal of Research and Reports in Hematology , cilt.5, sa.1, ss.27-33, 2022 (Hakemli Dergi)

37. The Prophylactic Treatment of COVID-19 in a Renal Failure and Hodgkin Lymphoma Patient with Convalescent Plasma

BİÇİM S., BERBER İ., ERKURT M. A., KUKU İ., KAYA E., BİLGİÇ Y., et al.

International Journal of Research and Reports in Hematology , cilt.5, sa.2, ss.1-5, 2022 (Hakemli Dergi)

38. Life saving effect of early use of convalescent plasma in Covid-19 treatment

SARICI A., ERKURT M. A., KUKU İ., BİÇİM S., BERBER İ., KAYA E., et al.

Annals of Medical Research , cilt.28, sa.12, ss.2242-2247, 2021 (Hakemli Dergi)

39. Pas III Added Donor Platelet Suspensions on Platelet Count Ph and Allergic Transfusion Reactions

Özgül M., KUKU İ., ERKURT M. A., SARICI A., BİÇİM S., BERBER İ., et al.

International Journal of Research and Reports in Hematology , cilt.4, sa.2, 2021 (Hakemli Dergi)

40. Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience

Sarıcı A., Erkurt M. A., Bahçecioğlu Ö. F., Tanriverdi L. H., Berber İ., Kaya E., et al.

Annals of Medical Research , cilt.28, sa.11, ss.2065-2070, 2021 (Hakemli Dergi)

41. Therapeutic plasma exchange for envenomation: Is it reasonable?

BERBER İ., Korkmaz S., SARICI A., ERKURT M. A., KUKU İ., KAYA E., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded)

42. Early therapeutic plasma exchange may improve treatment outcomes in severe acute toxic Hepatitis

BERBER İ., Cagin Y. F., ERDOĞAN M. A., Ataman E., GÖZÜKARA BAĞ H. G., ERKURT M. A., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

43. Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: A retrospective multicenter study

Dal Sinan M., Batgi H., ERKURT M. A., Hindilerden I. Y., KUKU İ., Kurtoglu E., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded)

44. The effect of therapeutic plasma exchange on management of HELLP Syndrome: The report of 47 patients

ERKURT M. A., SARICI A., KUKU İ., BERBER İ., KAYA E., Bicim S., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded)

45. Apheresis in patients with sepsis: A multicenter retrospective study

Aydin K., Korkmaz S., ERKURT M. A., SARICI A., Ekinci O., Baysal N. A., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded)

46. An innovation in stem cell harvesting: Heparin use

GÜL H. G., ERKURT M. A., SARICI A., KUKU İ., KAYA E., BERBER İ., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded)

47. Selection of the mobilization regimen in lymphoma patients: A retrospective cohort study

SARICI A., ERKURT M. A., KUKU İ., Gok S., Bahcecioglu O. F., Bicim S., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded)

48. A multicenter retrospective analysis on therapeutic plasma exchange in immune thrombocytopenic purpura

Basturk A., Sayin S., ERKURT M. A., SARICI A., Ekinci O., Kum A., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded)

49. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: A multicenter experience

Batgi H., Dal M. S., ERKURT M. A., KUKU İ., Kurtoglu E., Hindilerden I. Y., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.5, 2021 (SCI-Expanded)

50. Filgrastim alone versus cyclophosphamide and filgrastim for mobilization in multiple myeloma patients

SARICI A., ERKURT M. A., Bahcecioglu O. F., Gok S., KUKU İ., Bicim S., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.4, 2021 (SCI-Expanded)

51. Lenograstim versus filgrastim in mobilization before autologous hematopoietic stem cell transplantation in patients with multiple myeloma and lymphoma-Single center experience

SARICI A., ERKURT M. A., Bahcecioglu O. F., Bicim S., BERBER İ., Gok S., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.4, 2021 (SCI-Expanded)

52. FLAMSA vs BU-FLU in patients undergoing allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome

SARICI A., ERKURT M. A., KUKU İ., Gök S., Bahçecioğlu Ö. F., BİÇİM S., et al.

Medical Science and Discovery , cilt.8, sa.6, ss.356-360, 2021 (Hakemli Dergi)

53. Experience of ibrutinib in a patient with recurrent mantle cell lymphoma with orbital involvement

SARICI A., KUKU İ., KAYA E., ERKURT M. A., BERBER İ., BİÇİM S., et al.

Medicine Science , cilt.10, sa.4, ss.1542-1545, 2021 (Hakemli Dergi)

54. COVID-19 in hematopoietic cell transplant recipients

Altuntas F., Ata N., Yigenoglu T. N., Basci S., Dal M. S., Korkmaz S., et al.

BONE MARROW TRANSPLANTATION , cilt.56, sa.4, ss.952-955, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

55. Comparison of efficacy and toxicity of treosulfan-fludarabine and busulfan-cyclophosphamide conditioning regimens in patients undergoing allogeneic stem cell transplantation

SARICI A., ERKURT M. A., KUKU İ., BAHÇECİOĞLU Ö. F., GÖK S., BİÇİM S., et al.

Medicine Science , cilt.10, sa.4, ss.1133-1137, 2021 (Hakemli Dergi)

56. BK virus incidence, risk factors and its effect on mortality in hematopoietic stem cell transplant patients-single center experience

DEVİREN M. V., SARICI A., ERKURT M. A., BAHÇECİOĞLU Ö. F., BİÇİM S., BERBER İ., et al.

Medicine Science , cilt.10, sa.3, ss.856-859, 2021 (Hakemli Dergi)

57. The outcome of COVID-19 in patients with hematological malignancy

Yigenoglu T. N., Ata N., Altuntas F., Basci S., Dal M. S., Korkmaz S., et al.

JOURNAL OF MEDICAL VIROLOGY , cilt.93, sa.2, ss.1099-1104, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

58. Comparison of the renal response of bortezomib-based induction and conventional regimen in multiple myeloma patients with renal failure

SARICI A., KAYA E., ERKURT M. A., BERBER İ., TANRİVERDİ L. H., bahçecioğlu ö. f., et al.

Annals of Medical Research , cilt.28, sa.10, ss.1824-1829, 2021 (Hakemli Dergi)

59. The impact of laboratory features and comorbidities on the prognosis of patients with Covid-19

SARICI A., KIRICI BERBER N., Cağasar Ö., BİÇİM S., Yasir F. Ç., ULUTAŞ Ö., et al.

Journal of Health Sciences and Medicine , cilt.4, sa.2, ss.142-146, 2021 (Hakemli Dergi) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

60. COVID-19 clinical course and blood groups: Turkish population-based study

DAL M. S., Ata N., Altuntas F., Basci S., Yigenoglu T. N., Korkmaz S., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.4, ss.1659-1664, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

61. Peripheral Blood Smear Findings of COVID-19 Patients Provide Information about the Severity of the Disease and the Duration of Hospital Stay

BERBER İ., Cagasar O., SARICI A., Berber N. K., AYDOĞDU İ., ULUTAŞ Ö., et al.

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , cilt.13, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

62. Successful treatment with convalescent plasma in Covid-19 disease in relaps/refractory multiple myeloma

SARICI A., BİÇİM S., ERKURT M. A., BERBER İ., KAYA E., KUKU İ., et al.

Annals of Medical Research , cilt.28, sa.12, ss.2239-2241, 2021 (Hakemli Dergi) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

63. Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data

TOMBAK A., Tanrikulu F. P., Durusoy S. S., DİNÇYÜREK H. D., KAYA E., ÜMİT E. G., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.38, sa.4, ss.273-285, 2021 (SCI-Expanded)

64. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors

Basci S., Ata N., Altuntas F., Yigenoglu T. N., Dal M. S., Korkmaz S., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.7, ss.1676-1682, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

65. Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia

ERKURT M. A., SARICI A., BERBER İ., KUKU İ., KAYA E., Ozgul M.

TRANSFUSION AND APHERESIS SCIENCE , cilt.59, sa.5, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

66. Convalescent plasma therapy in patients withCOVID-19

Yigenoglu T. N., HACIBEKİROĞLU T., BERBER İ., Dal M. S., BAŞTÜRK A., Namdaroglu S., et al.

JOURNAL OF CLINICAL APHERESIS , cilt.35, sa.4, ss.367-373, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

67. Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study

Okay M., Aslan T., Ozdemir E., ÜNER A., Saglam A., Gungor E., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.2, ss.84-90, 2020 (SCI-Expanded)

68. Clinical Features and Laboratory Values Associated with Disease Severity in Covid 19 Patients: A Single Center Experience

KIRICI BERBER N., ULUTAŞ Ö., SARICI A., Yıldırım A., Çağaşar Ö., GÖZÜKARA BAĞ H. G., et al.

Journal of Health Sciences and Medicine , sa.1, ss.18-22, 2020 (Hakemli Dergi) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

69. Drug-drug interactions in intensive care units and potential clinical consequences of these interactions

OKSUZ E., BUĞDAY M. S., SOYALP C., KARAASLAN E., OTO G., TEMELLİ GOCEROGLU R., et al.

Annals of Medical Research , cilt.26, sa.10, ss.2158-2163, 2019 (Hakemli Dergi)

70. The Turkish experience with therapeutic plasma exchange: A national survey

Korkmaz S., Medeni S. S., DEMİRKAN F., Besisik S. K., Dadin S. A., ÇAĞLIYAN G. A., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.58, sa.3, ss.287-292, 2019 (SCI-Expanded)

71. The risk factors of portal vein thrombosis in patients with liver cirrhosis

Cagin Y. F., BİLGİÇ Y., Berber İ., YILDIRIM O., ERDOĞAN M. A., Firat F., et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE , cilt.17, sa.4, ss.3189-3194, 2019 (SCI-Expanded)

72. Enzyme Replacement Therapy in a Gaucher Family

Erdem N., Buran T., BERBER İ., Aydogdu I.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.110, sa.4, ss.330-333, 2018 (SCI-Expanded)

73. The effects of home oxygen therapy on energy metabolism in patients with COPD

Berber N. K., YETKİN Ö., Kilic T., Berber İ., Ozgel M.

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE , cilt.13, ss.1577-1582, 2018 (SCI-Expanded)

74. Eosinophilic ascites, as a rare manifestation of eosinophilic gastroenteritis: a case report

ÇAĞIN Y. F., BİLGİÇ Y., BERBER İ., ERDOĞAN M. A., YILDIRIM O., Altunel Kilinc E., et al.

Annals of Medical Research , cilt.25, sa.2, ss.284-287, 2018 (Hakemli Dergi)

75. EFFECTS OF RENAL REPLACEMENT THERAPY ON FIBROMYALGIA SYNDROME IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Berber İ., ŞAHİN İ., Gorgel A., Cagin Y. F., GÖZÜKARA BAĞ H. G., Berber N. K.

ACTA MEDICA MEDITERRANEA , cilt.34, sa.2, ss.337-343, 2018 (SCI-Expanded)

76. Assessing Safety of Pneumatic Tube System (PTS) for Patients with Very Low Hematologic Parameters

Koroglu M., ERKURT M. A., KUKU İ., KAYA E., Berber İ., Nizam I., et al.

MEDICAL SCIENCE MONITOR , cilt.22, ss.1329-1333, 2016 (SCI-Expanded)

77. Does the preference of peripheral versus central venous access in peripheral blood stem cell collection/yield change stem cell kinetics in autologous stem cell transplantation?

Dogu M. H., KAYA E., Berber İ., SARI İ., Tekgunduz E., ERKURT M. A., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.54, sa.1, ss.76-79, 2016 (SCI-Expanded)

78. Leukapheresis Treatment in Elderly Acute Leukemia Patients with Hyperleukocytosis: A Single Center Experience

BERBER İ., ERKURT M. A., KUKU İ., KAYA E., Bag H. G., NIZAM I., et al.

JOURNAL OF CLINICAL APHERESIS , cilt.31, sa.1, ss.53-58, 2016 (SCI-Expanded)

79. Primary central nervous system lymphoma in daily practice and the role of autologous stem cell transplantation in relapsed disease: A retrospective multicenter study

ERKURT M. A., Berber İ., Tekgunduz E., Dogu M. H., Korkmaz S., Demir C., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.54, sa.1, ss.80-84, 2016 (SCI-Expanded)

80. DHAP plus filgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory lymphoma: A single center experience

BERBER İ., ERKURT M. A., KUKU İ., Maya E., Bag H. G., NIZAM I., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.54, sa.1, ss.48-52, 2016 (SCI-Expanded)

81. A hundred years after the first article, a recollection: Cabot ring

Erdem N., Berber İ., AYDOĞDU İ., Sevinc A.

KOREAN JOURNAL OF INTERNAL MEDICINE , cilt.31, sa.1, ss.199, 2016 (SCI-Expanded)

82. The Role of Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia: Results of a Retrospective Multicenter Study

TOMBAK A., Ucar M. A., AKDENİZ A., TİFTİK E. N., ŞAHİN F., AKAY O. M., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.33, sa.4, ss.273-280, 2016 (SCI-Expanded)

83. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience

BERBER İ., KUKU İ., ERKURT M. A., KAYA E., Bag H. G., NIZAM I., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.53, sa.2, ss.185-190, 2015 (SCI-Expanded)

84. Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study

Korkmaz S., Dal M. S., Berber İ., Sahin D. G., Dogu M. H., Ayyildiz O., et al.

GERIATRICS & GERONTOLOGY INTERNATIONAL , cilt.15, sa.6, ss.729-735, 2015 (SCI-Expanded)

85. A life-saving therapy in Class I HELLP syndrome: Therapeutic plasma exchange

ERKURT M. A., Berber İ., Berktas H. B., KUKU İ., KAYA E., Koroglu M., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.52, sa.2, ss.194-198, 2015 (SCI-Expanded)

86. CLINICAL CHARACTERISTICS, POST-TREATMENT ASSESSMENT AND PROGNOSTIC FACTORS AFFECTING PATIENT SURVIVAL OF PATIENTS AT 65 YEARS OF AGE OR OLDER WITH HODGKIN LYMPHOMA: A RETROSPECTIVE MULTICENTER STUDY FROM TURKEY

Berber İ., ERKURT M. A., KEKLİK M., Dogu M. H., TERZİ H., Pala C., et al.

ACTA MEDICA MEDITERRANEA , cilt.31, sa.6, ss.1195-1202, 2015 (SCI-Expanded)

87. Can BuCyE conditioning regimen be an alternative treatment to BEAM at autologous transplantation in malignant lymphoma patients?: a single center experience

BERBER İ., ERKURT M. A., NIZAM I., KOROGLU M., KAYA E., KUKU İ., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.9, ss.16308-16314, 2015 (SCI-Expanded)

88. Thrombotic thrombocytopenic purpura presenting with pathologic fracture: a case report

Berber İ., ERKURT M. A., KUKU İ., KAYA E., Unlu S., ERTEM K., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.51, sa.1, ss.73-76, 2014 (SCI-Expanded)

89. As a Rare Disease Bernard Soulier Syndrome in Differential Diagnosis of Immune Thrombocytopenic Purpura A Case Report

BERBER İ., ERKURT M. A., YARARBAŞ K., KÖROĞLU M., NİZAM İ., BERKTAŞ H. B., et al.

American Journal of Medical Case Reports , cilt.2, sa.5, ss.102-106, 2014 (Hakemli Dergi)

90. BK Virus in Allogeneic and Autologous Bone Marrow Transplantation

BERBER İ., ERKURT M. A., KUKU İ., KAYA E.

American Journal of Medical Sciences And Medicine , 2014 (Hakemli Dergi)

91. Atypical Presentation of Plasmacytoma

BERBER İ., ERKURT M. A., YARARBAŞ K., KÖROĞLU M., NİZAM İ., BERKTAŞ H. B., et al.

American Journal of Medical Case Reports , cilt.2, sa.4, ss.82-83, 2014 (Hakemli Dergi)

92. Acute Myeloid Leukemia Significance of the Skin Test

BERBER İ., ERKURT M. A., YARARBAŞ K., KÖROĞLU M., NİZAM İ., BERKTAŞ H. B., et al.

American Journal of Medical Case Reports , cilt.2, sa.3, ss.55-56, 2014 (Hakemli Dergi)

93. Etiologic Factors of Nonalcoholic Hepatosteathosis in Malatya

GÜNDÜZ E., BENTLİ R., ULUTAŞ Ö., BERBER İ., ERKURT M. A.

Journal of Turgut Ozal MEdicine Center , cilt.21, sa.2, ss.130-134, 2014 (Hakemli Dergi)

94. Aggressive Progression of Mantle Cell Lymphoma ACase Report

NİZAM İ., ERKURT M. A., BERBER İ., KAYA E., KUKU İ., KÖROĞLU M.

American Journal of Medical Case Reports , cilt.2, sa.1, ss.30-31, 2014 (Hakemli Dergi)

95. Haploidentical Transplantation Experience in Turgut Ozal MedicalCenter Case Report and a Review of Literature

BERBER İ., ERKURT M. A., KAYA E., KÖROĞLU M., NİZAM İ., BENTLİ R., et al.

Journal of Turgut Ozal Medicine , cilt.21, sa.1, ss.55-58, 2014 (Hakemli Dergi)

96. BK Virus in Allogeneic and Autologous Bone Marrow Transplantation Review Article

BERBER İ., ERKURT M. A., YETKİN F., KUKU İ., KAYA E., bodakcı e., et al.

American Journal of Medical Sciences and Medicine , cilt.2, sa.5, ss.85-88, 2014 (Hakemli Dergi)

97. A Rare Disease in the Differential Diagnosis of Acute Pancreatitis: Acute Brucellosis

Berber İ., ERKURT M. A., YETKİN F., Unlu S., Yilmaz S., BENTLİ R., et al.

INTERNAL MEDICINE , cilt.53, sa.20, ss.2401-2404, 2014 (SCI-Expanded)

98. An Unexpected Complication of Bone Marrow Aspiration and Trephine Biopsy: Arteriovenous Fistula

Berber İ., ERKURT M. A., KUKU İ., KAYA E., KUTLU R., Koroglu M., et al.

MEDICAL PRINCIPLES AND PRACTICE , cilt.23, sa.4, ss.380-383, 2014 (SCI-Expanded)

99. Decitabine Induced Localized Maculopapular Eruption

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., NİZAM İ., KAYA E., et al.

British Journal of Medicine and Medical Research , cilt.4, sa.4, ss.1002-1007, 2014 (Hakemli Dergi)

100. Hermansky-Pudlak Syndrome: A Case Report

BERBER İ., ERKURT M. A., KUKU I., Kaya E., KOROGLU M., NIZAM I., et al.

CASE REPORTS IN HEMATOLOGY , cilt.2014, 2014 (ESCI)

101. Donor Selection in Allogeneic Stem Cell Transplantation

ERKURT M. A., BERBER İ., KUKU İ., KAYA E., NİZAM İ.

American Journal of Clinical Medicine Research , cilt.2, sa.1, ss.32-35, 2014 (Hakemli Dergi)

102. Clinicopathological Characteristics of Pernicious Anemia A Study of 300 Patients in Turkey

BENTLİ R., BERBER İ., ERKURT M. A., AYDOĞDU İ., GÜNDÜZ E., NİZAM İ., et al.

British Journal of Medicine and Medical Research , cilt.4, sa.3, 2013 (Hakemli Dergi)

103. Roles of CD5 CD19 CD41a CD55 and CD59 in Chronic Immune Thrombocytopenic Purpura ITP

kaya f., BERBER İ., ERKURT M. A., AYDOĞDU İ., REİSLİ İ.

British Journal of Medicine and Medical Research , cilt.4, sa.2, 2013 (Hakemli Dergi)

104. Primarily unknown origin adenocarcinoma metastasis in bone marrow presenting with thrombotic thrombocytopenic purpura: A case report

Koroglu M., ERKURT M. A., Berber İ., KUKU İ., KAYA E., Ozkahraman A., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.49, sa.2, ss.341-344, 2013 (SCI-Expanded)

105. Familial Chronic Lymphocytic Leukemia Patients in Eastern Anatolia Region

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., KAYA E., KUKU İ.

Journal Of Turgut Ozal Medical Center , cilt.20, sa.3, ss.287-288, 2013 (Hakemli Dergi)

106. Evans Seyndrome

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., KAYA E., KUKU İ.

Journal Of Turgut Ozal Medical Center , cilt.20, sa.3, ss.289-290, 2013 (Hakemli Dergi)

107. Extranasal NK Cell Lymphoma with Extensive Skin Involvement A Case Report

ERKURT M. A., BERBER İ., KARADAĞ N., BENTLİ R., KAYA E., KÖROĞLU M., et al.

Journal Of Turgut Ozal Medical Center , cilt.20, sa.3, ss.276-278, 2013 (Hakemli Dergi)

108. Therapeutic plasma-exchange in hematologic disease: Results from a single center in Eastern Anatolia

ERKURT M. A., Kuku L., KAYA E., Ozgen U., Berber İ., Koroglu M., et al.

TRANSFUSION AND APHERESIS SCIENCE , cilt.48, sa.3, ss.335-339, 2013 (SCI-Expanded)

109. Burkitt s lymphoma presenting with rapidly and multi organ involvement A case presentation

BERBER İ., ERKURT M. A., KÖROĞLU M., KUKU İ., KAYA E., BENTLİ R.

Case Reports in Clinical Medicine , cilt.2, sa.04, ss.242-245, 2013 (Hakemli Dergi)

110. Double Hit Lymphoma Presenting with Aggressive Progression A CaseReport

KAYA E., ERKURT M. A., BERBER İ., KÖROĞLU M., KUKU İ.

Journal Of Turgut Ozal Medical Center , cilt.20, sa.1, ss.74-76, 2013 (Hakemli Dergi)

111. Pulmonary Embolism as the Initial Presentation of Testicular Carcinoma

BERBER İ., BENTLİ R., ERKURT M. A., ULUTAŞ Ö., EDİZ C., NİZAM İ., et al.

CASE REPORTS IN ONCOLOGICAL MEDICINE , cilt.2013, 2013 (ESCI) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

112. Doğu Anadolu Bölgesindeki Ailesel Kronik Lenfositik Lösemili Hastalarımız

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., KAYA E., KUKU İ.

İnönü Üniversitesi Tıp Fakültesi Dergisi , cilt.20, sa.3, ss.287-288, 2013 (Hakemli Dergi)

113. A Rare Case of Chronic Myeloid Leukemia At a Patient with Achondroplasia

NİZAM İ., ERKURT M. A., BERBER İ., KAYA E., KUKU İ.

American Journal of Medical Case Reports , 2013 (Hakemli Dergi)

114. Evans Syndrome

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., KAYA E., KUKU İ.

İnönü Üniversitesi Tıp Fakültesi Dergisi , cilt.20, sa.3, ss.289-290, 2013 (Hakemli Dergi)

115. Hypernatremia in the Emergency Department

YÜCEL N., ŞAHİN İ., AKGÜN F. S., KÖZ S., BERBER İ., Özdemir M. G.

TURKISH NEPHROLOGY, DIALYSIS AND TRANSPLANTATION JOURNAL , cilt.21, sa.02, ss.124-129, 2012 (ESCI)

116. Hipertansiyonu Renal İnfarktı ve MorgagniHernisi Olan Marfan Sendromlu Bir Olgu

karahan d., ŞAHİN İ., toylak e., BERBER İ., TAŞKAPAN H.

Journal of Turgut Ozal Medical Center , cilt.16, sa.4, ss.257-259, 2009 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 19

1. REFRAKTER KRONİK İTP’ DE DANAZOL TEDAVİSİ

ARSLAN S., KAYA E., KUKU İ., ERKURT M. A., BERBER İ., KAYA A.

50. Ulusal Hematoloji Kongresi - 2024, 29 Ekim - 02 Kasım 2024, (Özet Bildiri)

2. SIÇANLARDA DENEYSEL OLARAK KARACİĞERDE BİRİKEN BAKIR ÜZERİNE HUMİK ASİTİN ETKİSİNİN ARAŞTIRILMASI

KİREÇ Y., ÇAĞIN Y. F., ÖZHAN O., YILDIZ A., DOĞRU F., BERBER İ.

2. Uluslararası ve 27. Ulusal Farmakoloji Kongresi, Antalya, Türkiye, 23 Kasım 2023, (Özet Bildiri)

3. İnönü University Turgut Özal Medical Center Red Crescent Pool Platelet Experience

HİDAYET E., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.

WORLD APHERESIS ASSOCIATION THE EUROPEAN SOCIETY FOR HEMAPHERESIS THE TURKISH SOCIETY OF HEMATOLOGICAL RARE DISEASES HYBRID JOINT CONGRESS, İstanbul, Türkiye, 14 - 17 Eylül 2022, (Tam Metin Bildiri)

4. Covid-19 Hastalarında Hastalık Şiddetiyle İlişkili Klinik Özellikler ve Laboratuvar Değerleri : Tek Merkez Deneyimi

YILDIRIM A., KIRICI BERBER N., ULUTAŞ Ö., SARICI A., ÇAĞAŞAR Ö., GÖZÜKARA BAĞ H. G., et al.

II. Hematoloji Eğitim ve Araştırma Kongresi, Türkiye, 20 - 22 Kasım 2020, (Özet Bildiri)

5. Covid-19 Hastalarının Basit Periferik Yayma Bulgularının, Hastalığın Ciddiyeti ve Hastanede Kalış Süresi Üzerindeki Yararları

KIRICI BERBER N., BERBER İ., ÇAĞAŞAR Ö., SARICI A., AYDOĞDU İ., ULUTAŞ Ö., et al.

II. Hematoloji Eğitim ve Araştırma Kongresi, Türkiye, 20 - 22 Kasım 2020, (Özet Bildiri)

6. TANI ANINDA BÖBREK YETMEZLİĞİ OLAN MULTİPL MYELOM HASTALARININ TEDAVİ SONRASI BÖBREK FONKSİYONLARININ DEĞİŞİMİ

SARICI A., KAYA E., ERKURT M. A., TANRIVERDİ L. H., BERBER İ., BAHÇECİOĞLU Ö. F., et al.

45. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 30 Ekim - 02 Kasım 2019, ss.219, (Özet Bildiri)

7. Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study

Tombak A., Tanrikulu F. P., Durusoy S. S., GÜRKAN E., KAYA E., ÜMİT E. G., et al.

61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 7 - 10 Aralık 2019, cilt.134, (Özet Bildiri)

8. Deri Tutulumu İle Prezente Extranodal NHL Olgu Sunumu

KUM A., ERKURT M. A., NİZAM İ., BERBER İ., KAYA E., KUKU İ., et al.

10.Ulusal Aferez Kongresi, İstanbul, Türkiye, 5 - 08 Kasım 2015, (Tam Metin Bildiri)

9. Kadın Hastada Hemofili A

ÖZEN NİZAM İ., ERKURT M. A., KAYA E., BERBER İ., DOLAŞIK İ., CÖMERT ÖZKAN M., et al.

10.Ulusal Aferez Kongresi, İstanbul, Türkiye, 5 - 08 Kasım 2015, (Tam Metin Bildiri)

10. UYGUN DONÖRLERDE ÜÇLÜ DOZ TROMBOSİT AFEREZİ DOĞU ANADOLU DAN TEK MERKEZ DENEYİMİ

ÖZGÜL M., ÖZEN İ. N., ERKURT M. A., KUKU İ., BERBER İ., DOLAŞIK İ., et al.

10.AFEREZ KONGRESİ, Türkiye, 5 - 08 Kasım 2015, (Tam Metin Bildiri)

11. Leukapheresis in elderly patients are safe and effective treatment

BERBER İ., ERKURT M. A., KUKU İ., KAYA E., NİZAM İ., GÖZÜKARA BAĞ H. G., et al.

IX. Ulusal Aferez Kongresi, Kıbrıs (Kktc), 4 - 07 Eylül 2014, ss.177-178, (Özet Bildiri)

12. Bu Cy E Conditioning Regimen Can Be An Alternative Treatment to BEAM at Autologous Transplantation for Lymphoma

ERKURT M. A., BERBER İ., NİZAM İ., KAYA E., KUKU İ.

IX. Ulusal Aferez Kongresi, Türkiye, 4 - 07 Eylül 2014

13. The clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study.

Korkmaz S., Dal M. S., Berber İ., Sahin D. G., Dogu M. H., Ayyildiz O., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)

14. PRIMARY BREAST LYMPHOMA IN A MALE PATIENT

BERBER İ., ERKURT M. A., yiğit a., KAYA E., KUKU İ., KÖROĞLU M., et al.

IV. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS, Antalya, Türkiye, 9 - 13 Ekim 2013, cilt.3, ss.129

15. CHRONIC MYELOİD LEUKEMIA PRESENTING A MAN WİTH A AT CHONDROPLASIA A RARE CASEINTRODUCTlON

NİZAM İ., ERKURT M. A., KAYA E., KÖROĞLU M., BERBER İ., BENTLİ R., et al.

4. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS, 9 - 13 Ekim 2013

16. AKUT MYELOİD LÖSEMİDE CİLT MUAYENESİ VE ÖNEMİ

BERBER İ., ERKURT M. A., KAYA E., NİZAM İ., KUKU İ., KÖROĞLU M., et al.

8. ULUSAL AFEREZ KONGRESİ, Kıbrıs (Kktc), 5 - 08 Eylül 2013

17. KEMİK İLİĞİ İNCELEMESİ SONRASINDA NADİR BİR KOMPLİKASYON A V FİSTÜL

BERBER İ., ERKURT M. A., BAZNA S., KAYA E., NİZAM İ., KÖROĞLU M., et al.

8. ULUSAL AFEREZ KONGRESİ, Kıbrıs (Kktc), 5 - 08 Eylül 2013, ss.149-150

18. HEMATOLOJİ KONSÜLTASYONU İSTENEN HASTALARIN BÖLÜMLERE VE İSTEM NEDENLERİNE GÖRE DAĞILIMI

KÖROĞLU M., ERKURT M. A., BERBER İ., KAYA E., KUKU İ.

38. ULUSAL HEMATOLOJİ KONGRESİ, Türkiye, 31 Ekim - 04 Kasım 2012

19. KEMİK İLİĞİ NAKİL MERKEZİ KÜLTÜR SONUÇLARIMIZ TEK MERKEZ DENEYİMİ

KÖROĞLU M., BERBER İ., KAYA E., ERKURT M. A., KUKU İ.

7. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Türkiye, 8 - 10 Mart 2012, ss.171, (Özet Bildiri)

Metrikler

Yayın

143

Yayın (WoS)

63

Yayın (Scopus)

58

Atıf (WoS)

274

H-İndeks (WoS)

8

Atıf (Scopus)

135

H-İndeks (Scopus)

5

Atıf (Scholar)

3

H-İndeks (Scholar)

1

Atıf (TrDizin)

4

H-İndeks (TrDizin)

1

Atıf (Sobiad)

2

H-İndeks (Sobiad)

1

Atıf (Diğer Toplam)

7

Proje

3

Açık Erişim

7

BM Sürdürülebilir Kalkınma Amaçları